Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

Similar articles for PubMed (Select 24383942)

1.

Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study).

Messina C, Ferreri AJ, Govi S, Bruno-Ventre M, Gracia Medina EA, Porter D, Radford J, Heo DS, Park HY, Pro B, Jayamohan J, Visco C, Scarfò L, Zucca E, Gospodarowicz M, Christie D; International Extranodal Lymphoma Study Group (I.E.L.S.G.).

Br J Haematol. 2014 Mar;164(6):834-40. doi: 10.1111/bjh.12714. Epub 2014 Jan 2.

PMID:
24383942
2.

Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study).

Bruno Ventre M, Ferreri AJ, Gospodarowicz M, Govi S, Messina C, Porter D, Radford J, Heo DS, Park Y, Martinelli G, Taylor E, Lucraft H, Hong A, Scarfò L, Zucca E, Christie D; International Extranodal Lymphoma Study Group.

Oncologist. 2014 Mar;19(3):291-8. doi: 10.1634/theoncologist.2013-0249. Epub 2014 Feb 24.

3.

The clinical features, management and prognostic effects of pathological fractures in a multicenter series of 373 patients with diffuse large B-cell lymphoma of the bone.

Govi S, Christie D, Messina C, Bruno Ventre M, Gracia Medina EA, Porter D, Radford J, Seog Heo D, Park Y, Martinelli G, Taylor E, Lucraft H, Ballova V, Zucca E, Gospodarowicz M, Ferreri AJ; International Extranodal Lymphoma Study Group (I.E.L.S.G.).

Ann Oncol. 2014 Jan;25(1):176-81. doi: 10.1093/annonc/mdt482. Epub 2013 Nov 28.

4.

Prognostic significance of soft tissue extension, international prognostic index, and multifocality in primary bone lymphoma: a single institutional experience.

Wu H, Zhang L, Shao H, Sokol L, Sotomayor E, Letson D, Bui MM.

Br J Haematol. 2014 Jul;166(1):60-8. doi: 10.1111/bjh.12841. Epub 2014 Mar 27.

PMID:
24673481
5.

A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.

Li X, Xia B, Guo S, Zhan Z, Zhang L, Zhao D, Wu X, Zhang Y.

Ann Hematol. 2013 Jun;92(6):807-15. doi: 10.1007/s00277-013-1701-9. Epub 2013 Feb 17.

PMID:
23417758
6.

Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study.

Yhim HY, Kang HJ, Choi YH, Kim SJ, Kim WS, Chae YS, Kim JS, Choi CW, Oh SY, Eom HS, Kim JA, Lee JH, Won JH, Shim H, Lee JJ, Sung HJ, Kim HJ, Lee DH, Suh C, Kwak JY.

BMC Cancer. 2010 Jun 22;10:321. doi: 10.1186/1471-2407-10-321.

7.

Diffuse large B-cell lymphoma with central nervous system relapse: prognosis and risk factors according to retrospective analysis from a single-center experience.

Shimazu Y, Notohara K, Ueda Y.

Int J Hematol. 2009 Jun;89(5):577-83. doi: 10.1007/s12185-009-0289-2. Epub 2009 Apr 9.

PMID:
19353238
8.

Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group.

Huang JZ, Weisenburger DD, Vose JM, Greiner TC, Aoun P, Chan WC, Lynch JC, Bierman PJ, Armitage JO; Nebraska Lymphoma Study Group.

Leuk Lymphoma. 2003 Nov;44(11):1903-10.

PMID:
14738141
9.

Clinical disparity and favorable prognoses for patients with Waldeyer ring extranodal nasal-type NK/T-cell lymphoma and diffuse large B-cell lymphoma.

Wu RY, Li YX, Wang WH, Jin J, Wang SL, Liu YP, Song YW, Fang H, Ren H, Liu QF, Wang ZY, Qi SN, Lu NN, Chen B, Zhang XM, Zhou LQ, Liu XF, Yu ZH.

Am J Clin Oncol. 2014 Feb;37(1):41-6. doi: 10.1097/COC.0b013e318261084b.

PMID:
22992625
10.

Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group.

Huang JZ, Weisenburger DD, Vose JM, Greiner TC, Aoun P, Chan WC, Lynch JC, Bierman PJ, Armitage JO.

Leuk Lymphoma. 2004 Aug;45(8):1551-7.

PMID:
15370206
11.

Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.

Abdelhamid T, Samra M, Ramadan H, Mehessin M, Mokhtar N.

J Egypt Natl Canc Inst. 2011 Mar;23(1):17-24. doi: 10.1016/j.jnci.2011.07.003. Epub 2011 Sep 8.

12.

Ocular adnexal diffuse large B-cell lymphoma: a multicenter international study.

Munch-Petersen HD, Rasmussen PK, Coupland SE, Esmaeli B, Finger PT, Graue GF, Grossniklaus HE, Honavar SG, Khong JJ, McKelvie PA, Mulay K, Prause JU, Ralfkiaer E, Sjö LD, Sniegowski MC, Vemuganti GK, Heegaard S.

JAMA Ophthalmol. 2015 Feb;133(2):165-73. doi: 10.1001/jamaophthalmol.2014.4644.

PMID:
25393033
13.

Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.

Ang MK, Hee SW, Quek R, Yap SP, Loong S, Tan L, Tao M, Lim ST.

Ann Hematol. 2009 May;88(5):417-24. doi: 10.1007/s00277-008-0604-7. Epub 2008 Sep 7.

PMID:
18777110
14.

Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group.

Ryan G, Martinelli G, Kuper-Hommel M, Tsang R, Pruneri G, Yuen K, Roos D, Lennard A, Devizzi L, Crabb S, Hossfeld D, Pratt G, Dell'Olio M, Choo SP, Bociek RG, Radford J, Lade S, Gianni AM, Zucca E, Cavalli F, Seymour JF; International Extranodal Lymphoma Study Group.

Ann Oncol. 2008 Feb;19(2):233-41. Epub 2007 Oct 11.

16.

[Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].

Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.

Ai Zheng. 2006 Dec;25(12):1543-9. Chinese.

PMID:
17166383
17.

[Clinical characteristics and prognosis of diffuse large B-cell lymphoma].

Yang BY, Yong WB, Zhu J, Zheng W, Zhang YT, Wang XP, Meng SN.

Zhonghua Zhong Liu Za Zhi. 2005 Mar;27(3):174-6. Chinese.

PMID:
15946571
18.

The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma.

Arkenau HT, Chong G, Cunningham D, Watkins D, Agarwal R, Sirohi B, Trumper M, Norman A, Wotherspoon A, Horwich A.

Ann Oncol. 2007 Mar;18(3):541-5. Epub 2006 Dec 12.

19.

Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy.

Yhim HY, Kim JS, Kang HJ, Kim SJ, Kim WS, Choi CW, Eom HS, Kim JA, Lee JH, Won JH, Shim H, Huh J, Lee DH, Suh C, Kwak JY.

Int J Cancer. 2012 Jul 1;131(1):235-43. doi: 10.1002/ijc.26352. Epub 2011 Aug 30.

PMID:
21823120
20.

Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma.

Kim SJ, Oh SY, Kim JS, Kim H, Lee GW, Won JH, Shin HJ, Yang DH, Choi CW, Park J, Kim WS, Suh C.

Ann Hematol. 2011 May;90(5):539-46. doi: 10.1007/s00277-010-1104-0. Epub 2010 Oct 20.

PMID:
20960190
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk